Journal
BLOOD
Volume 132, Issue 1, Pages 1-3Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-05-848366
Keywords
-
Categories
Ask authors/readers for more resources
In this issue of Blood, LaCasce et al present data on the incorporation of brentuximab vedotin (BV) with bendamustine (BVB) in patients with recurrent/ refractory classical Hodgkin lymphoma (HL) that might be practice-changing.(1)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
